Whitepapers

As the race to deliver advanced gene therapies accelerates, AAV production must keep pace—with no room for inconsistency. This article dives into how high-performance cell culture media is unlocking new levels of reliability, scalability, ... read more

Cutting-edge molecular tools are transforming the way cell therapy products are analyzed, offering faster, more sensitive, and less invasive testing methods compared to traditional approaches. This article explores how techniques like qPCR,... read more

Are you looking to achieve scalable, high-titer manufacturing of high-quality rAAV products? Achieve your goal with the next-generation Xcellerex™ X-platform single-use bioreactor used in tandem with the ELEVECTA™ transient cell line and ... read more

As the cell and gene therapy (CGT) industry rapidly expands, maintaining product safety and quality is more critical than ever. One of the most pressing concerns is the threat of adventitious agents—unintended microbial contaminants that ... read more

Safely introducing transgenes into cells is one of the greatest challenges facing the field of gene therapy. Using viral vectors has become one of the most effective means to achieve this by taking advantage of a virus’s natural ability to ... read more